403 completed, 149 unknown, 71 terminated, 56 withdrawn. 722 Phase 1, 268 Phase 2.
Follow Coronavirus Infections: new trials by email Literature Review of Coronavirus Infections trials Research Report on Coronavirus Infections
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of the Safety and Efficacy of XoGlo Pro, a Placental Mesenchymal Stem Cell-derived Extracellular Vesicles in Treating COVID-19 Symptoms IV infusion using an isolated, placental, mesenchymal stem cell derived EVs, Placebo IV administration - COVID-19 | Phase 1 / Phase 2 | Not yet recruiting | Kimera Labs Inc. | 64 | 2027-01-01 | 2026-06-24 |
| Taurine Supplementation in Adolescents With Post-COVID Condition Taurine - Long COVID, Post COVID-19 Condition | Phase 1 / Phase 2 | Not yet recruiting | University of Alberta | 30 | 2026-12-30 | 2026-10-16 |
| Evaluating AVM0703 for Treatment of COVID-19 or Influenza-mediated ARDS AVM0703, Placebo - ARDS, Covid19 | Phase 1 | Not yet recruiting | AVM Biotechnology Inc | 16 | 2026-12-01 | 2026-11-02 |
| Phase I Open-Label Safety Trial of Pembrolizumab for Neurological Post- Acute Sequelae of SARS-CoV-2 (PD1-PASC I) Keytruda - Post-Acute COVID-19 Syndrome | Phase 1 | Not yet recruiting | National Institute of Neurological Disorders and Stroke (NINDS) | 15 | 2026-11-25 | 2026-11-20 |
| Pancoronavirus Vaccine Study in Healthy Adults Ages 18-55 Cov-RBD-scNP-001, ACU-026-001-1 - Coronavirus Infection | Phase 1 | Not yet recruiting | Duke University | 36 | 2026-11-16 | 2026-10-29 |
| A Safety, Reactogenicity and Immunogenicity Trial of RVX-sCPD9 Booster Intranasal COVID-19 Vaccine RVX-sCPD9 - COVID -19 | Phase 1 | Not yet recruiting | National Institute of Allergy and Infectious Diseases (NIAID) | 80 | 2026-10-26 | 2026-11-20 |
| Safety, Tolerability, and Immunogenicity of BMI2012 Against COVID-19 Variant in Healthy Adults Aged 19 and 55 Years BMI2012 low-dose, Placebo low-dose, BMI2012 mid-dose - Prevention of COVID-19 Variant (Omicron JN.1) | Phase 1 | Not yet recruiting | BMI Korea | 72 | 2026-10-01 | 2026-08-28 |
| Development of a Controlled Human Infection Model for Assessment of SARS-CoV-2 Omicron Subvariants SARS-CoV-2 Omicron EG.5.1 challenge agent 10^5 TCID50, SARS-CoV-2 Omicron EG.5.1 challenge agent 10^6 TCID50, SARS-CoV-2 Omicron EG.5.1 challenge agent 10^4 TCID50 - SARS-CoV-2 (COVID-19) | Phase 1 | Recruiting | Imperial College London | 38 | 2026-07-10 | 2026-07-17 |
| Bio-Manguinhos/Fiocruz COVID-19 (mRNA) Vaccine Booster Grupo 1 - dose 25 μg, Group 2 - 50 μg dose, Group 3 - 100 μg - Severe Acute Respiratory Syndrome (SARS-CoV-2 Virus) | Phase 1 | Not yet recruiting | The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) | 90 | 2026-07-01 | 2026-06-10 |
| Use of hUC-MSC Product (BX-U001) for the Treatment of COVID-19 With ARDS Human umbilical cord mesenchymal stem cells + best supportive care, Placebo control + best supportive care - COVID-19, ARDS | Phase 1 / Phase 2 | Withdrawn | Baylx Inc. | 2026-06-01 | 2025-12-29 | |
| A Safety and Immunogenicity Trial of OCU500, ChAd36 Vector Encoding SARS-CoV-2 Spike Vaccine Via Intranasal and Inhalational Routes in Previously Vaccinated Adults OCU500 - COVID-19 | Phase 1 | Active not recruiting | National Institute of Allergy and Infectious Diseases (NIAID) | 83 | 2026-05-26 | 2026-11-20 |
| A Study of How Ibuzatrelvir is Taken up Into the Blood of Healthy Adults After Taking Different Tablets of Ibuzatrelvir Ibuzatrelvir co-process API film coated tablet, Ibuzatrelvir filmcoated tablet - Coronavirus Disease 2019, Coronavirus Disease 2019 (COVID-19) | Phase 1 | Completed | Pfizer | 17 | 2026-04-13 | 2026-07-28 |
| A Study Evaluating MDX2301 in Healthy Adults and Adults at Higher Risk for Severe COVID-19. MDX2301, Normal Saline - COVID -19, COVID-19 (Prevention) | Phase 1 | Recruiting | ModeX Therapeutics, An OPKO Health Company | 80 | 2026-03-24 | 2026-09-10 |
| Kisspeptin to Quantify GnRH Neuronal Function in Health and Disease Kisspeptin 112-121 - Reproductive Disorder, Neurodegeneration | Phase 1 | Recruiting | Stephanie B. Seminara, MD | 40 | 2026-03-10 | 2026-07-13 |
| A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults Investigational mRNA Seasonal Flu/COVID-19 Combination (Flu/COVm) Vaccine, Licensed Seasonal Influenza Vaccine, Licensed COVID-19 Vaccine - Influenza, Human+COVID-19 | Phase 1 | Recruiting | GlaxoSmithKline | 225 | 2026-03-09 | 2026-06-30 |
| Effect of COV2 Vaccine Formulation on the Ability to Generate Antibodies Against Coronavirus That Causes COVID-19 COVID-19 Vaccines - COVID - 19, SARS CoV-2 | Phase 1 | Active not recruiting | Rokote Laboratories Finland Oy | 20 | 2026-02-10 | 2026-07-22 |
| Safety and Immunogenicity Trial of PepGNP-COVID19 Vaccine in Adults PepGNP-COVID19, Sterile Water for Injection - COVID-19 | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 60 | 2026-02-02 | 2026-10-30 |
| A Phase 1 Study to Evaluate the Safety and Immunogenicity of GC4006A in Healthy Adults GC4006A, Normal Saline - COVID - 19 | Phase 1 | Active not recruiting | GC Biopharma Corp | 72 | 2026-01-28 | 2026-11-16 |
| A Safety and Immunogenicity Trial of Boost-2867 Vaccine, Via Intranasal and Intramuscular Routes Aluminum Hydroxide Suspension, Boost-2867, CpG 7909 - COVID-19 | Phase 1 | Active not recruiting | National Institute of Allergy and Infectious Diseases (NIAID) | 140 | 2025-12-05 | 2026-11-20 |
| A Phase 1/2A, Randomized Study of a T Follicular Helper (TFH)-Targeting Genetic Vaccine Strategy Designed to Induce Broad, Durable Immune Responses CoTend-BXBB (SARS2-30404), CoTend-s3BXBB (SARS2-17032), Placebo - COVID-19, SARS-CoV-2 Infection | Phase 1 / Phase 2 | Recruiting | Kara Chew | 80 | 2025-10-21 | 2026-08-18 |
Showing 20 of 722. Sign in to see all of them.
COVID-19 (675) · Respiratory Distress Syndrome (34) · Severe Acute Respiratory Syndrome (33) · Pneumonia (25) · Virus Diseases (23) · Post-Acute COVID-19 Syndrome (14) · Pneumonia, Viral (12) · Acute Lung Injury (10) · Influenza, Human (10) · Infections (9) · Communicable Diseases (8) · Cytokine Release Syndrome (7) · Lung Diseases (7) · Respiratory Tract Infections (7)
Coronaviridae Infections (721) · Nidovirales Infections (721) · RNA Virus Infections (718) · Infections (713) · Virus Diseases (699) · Respiratory Tract Diseases (691) · Respiratory Tract Infections (685) · Lung Diseases (680) · Pneumonia, Viral (673) · Pneumonia (661) · Pathological Conditions, Signs and Symptoms (66) · Pathologic Processes (56) · Respiration Disorders (46) · Disease Attributes (29)
Saline Solution (26) · Sodium Chloride (26) · Standard of Care (19) · Ritonavir (12) · nirmatrelvir and ritonavir drug combination (12) · COVID-19 Vaccines (10) · BNT162 Vaccine (9) · Injections (9) · nirmatrelvir (9) · Ivermectin (8) · 2019-nCoV Vaccine mRNA-1273 (7) · ChAdOx1 nCoV-19 (7) · COVID-19 Serotherapy (6) · CVnCoV COVID-19 vaccine (6) · Hydroxychloroquine (6)
Pfizer (25) · National Institute of Allergy and Infectious Diseases (NIAID) (18) · AstraZeneca (9) · ImmunityBio, Inc. (8) · BioNTech SE (7) · Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation (7) · Regeneron Pharmaceuticals (7) · Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. (6) · University of Oxford (6) · GeneOne Life Science, Inc. (5) · GlaxoSmithKline (5) · Sinocelltech Ltd. (5) · Sorrento Therapeutics, Inc. (5) · Stanford University (5) · CanSino Biologics Inc. (4)
United States (233) · China (81) · Australia (32) · United Kingdom (28) · Brazil (27) · Russia (20) · South Korea (20) · Belgium (19) · Canada (17) · Germany (17) · Mexico (16) · South Africa (16) · Israel (13) · Spain (12) · Indonesia (11)
Mike Royal, MD (4) · Fengcai Zhu, Doctor (3) · William Cameron, MD (3) · Yao Zhang (3) · Anya Loncaric (2)
PMID 34473343, PMID 35713300, PMID 36435633, PMID 37231296, PMID 31986264, PMID 36147329, PMID 32125452, PMID 32257537, PMID 32896291, PMID 33306989, PMID 33617777, PMID 33873199, PMID 34551869, PMID 34658014, PMID 34890537, PMID 35316221, PMID 35547849, PMID 35660738, PMID 37354048, PMID 37699630, PMID 38181791, PMID 39636474, PMID 39749328, PMID 40632654, PMID 10051178, PMID 10415784, PMID 10669330, PMID 11023960, PMID 110688, PMID 11440640, PMID 11886437, PMID 12563677, PMID 1406879, PMID 14719037, PMID 15663512, PMID 16011702, PMID 16051812, PMID 16625202, PMID 16787239, PMID 17181919, PMID 18073382, PMID 18097874, PMID 18369153, PMID 18552864, PMID 18778201, PMID 19355966, PMID 19397687, PMID 19420084, PMID 19453649, PMID 19564349
2023 (6), 5UM1AI148373-05 (2), 5UM1AI148684-02 (2), 2025 (1), 272201300017C-18-0-1 (1), P30CA033572 (1), P30CA047904 (1), P30CA138292 (1), R01HL109448 (1), R37HD043341 (1), R44HL158446 (1), U01AI172800 (1)